North Ogden, UT, United States of America

Louis F Cannizzo

This inventor holds 21 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Alliant Techsystems Inc., Epicentrx, Inc., Orbital Atk, Inc.. Active years: 1996-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Louis F Cannizzo. Retrieved from https://idiyas.com/inventor/louis-f-cannizzo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 85.7


 

Average Co-Inventor Count = 4.2

ph-index = 9

Forward Citations = 197(Granted Patents)


Location History:

  • North Ogden, UT (US) (2002 - 2006)
  • Ogden, UT (US) (1996 - 2024)

Company Filing History:


Years Active: 1996-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cyclic Nitro Compounds
Pharmaceutical Compositions
Cancer Treatment
Energetic Materials
Nitramines Recovery
Acyclic Organonitro Compounds
Thermoplastic Elastomers
Polymerization
Explosive Compositions
Synthesis Methods
Pyrotechnics
O-nitro Compounds
21 patents (USPTO):Explore Patents

Title: Louis F Cannizzo: Pioneering Innovator from North Ogden

Introduction:

Louis F Cannizzo, a prolific inventor hailing from North Ogden, UT, has made significant contributions to the field of pharmaceuticals with a total of 20 patents to his name. His groundbreaking work in cyclic nitro compounds has revolutionized the treatment and prevention of diseases characterized by abnormal cell proliferation.

Latest Patents:

One of Cannizzo's latest patents is for cyclic nitro compounds, pharmaceutical compositions thereof, and their uses in treating diseases such as cancer, inflammation, cardiovascular disease, and autoimmune disorders. This innovative approach showcases his commitment to advancing medical science and improving healthcare outcomes.

Career Highlights:

Throughout his career, Cannizzo has worked with esteemed companies such as Alliant Techsystems Inc. and Radiorx, Inc. His expertise and dedication have led to the successful development and implementation of cutting-edge pharmaceutical solutions. By bridging the gap between research and practical application, he has solidified his reputation as a leader in the field.

Collaborations:

Collaborating with talented individuals is key to Cannizzo's success. Among his notable coworkers are Kirstin F Warner and Robert B Wardle, both of whom have contributed significantly to the projects they have worked on together. These collaborations have enriched his work and accelerated the pace of innovation in the industry.

Conclusion:

Louis F Cannizzo's innovative spirit and relentless pursuit of excellence have propelled him to the forefront of pharmaceutical innovation. His patents stand as a testament to his vision and dedication to improving patient care and advancing medical science. As he continues to push the boundaries of what is possible in the field, the impact of his work is sure to be felt for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…